Talwalkars - Q2FY13 Result Update - Centrum

Talwalkars Better Value Fitness

Buy

Target Price: Rs219

CMP: Rs191

Upside: 15%

Strong operating performance

TBVF posted strong operating results with net sales at Rs501mn on the back of robust August scheme where the company had a renewal rate of 76% after price hike of 6-8%. Increasing investments in ZUMBA and weight loss program ‘REDUCE’ too helped the company increase same store sales growth. Margin expansion of 438bps on the back of cost control and royalty income helped the company post 47% YoY increase in profitability. We maintain BUY rating on the stock.

FII DERIVATIVES STATISTICS FOR 19-Oct-2012

FII DERIVATIVES STATISTICS FOR 19-Oct-2012
	BUY		SELL		OPEN INTEREST AT THE END OF THE DAY
	No. of contracts	Amt in Crores	No. of contracts	Amt in Crores	No. of contracts	Amt in Crores
INDEX FUTURES	55801	1589.21	66577	1871.75	622617	15622.37	-282.53
INDEX OPTIONS	701360	19949.16	681339	19387.15	1859086	52857.20	562.01
STOCK FUTURES	169366	4868.11	168258	4893.88	1072645	31401.69	-25.76
STOCK OPTIONS	62555	1903.33	62560	1918.88	92284	2919.92	-15.55
						Total	238.16

 

 

-- 

Angel Broking - Derivatives Report - 19.10.2012

Derivatives Report

Angel Broking - Market Outlook- 19.10.2012

Market Outlook

Angel Broking - Market Summary - 19.10.2012

Market Summary

Angel Broking - Technical Report - 19.10.2012

Technical Report

Ambuja Cement Ltd. Q3 FY13 :Microsec

Ambuja Cement Ltd.  announced its Q3 FY13 results on 18th October 2012. The company’s Standalone Net sales increased by 20% on YoY basis but decline by 16% on QoQ. EBITDA increased by 99% on YoY but decline by  17% on  QoQ basis. EBITDA Margin of the company decreased from 28.53% to 27.91% on QoQ. Standalone PAT increased by 77% on YoY but decline by  35% on QoQ basis.

Particulars	Consensus Est	Actual	Var (%)
Revenues	2188	2,175	-0.6%
EBITDA	607	466	-23.2%
PAT	336	304	-9.4%
Ajd.EPS	2.10	1.97	-6.2%

STANDALONE
DESCRIPTION	September-12	September-11	June-12	YoY Change(%)	QoQ Change(%)
Total Income	2,175	1820	2,579	20	-16
Total Expenditure	1,568	1514	1,844	4	-15
EBITDA	607	305	736	99	-17
EBITDA margins	27.91%	16.79%	28.53%
Other Income	89	72	78
Operating Profit	697	377	813
Interest	17	14	18
Exceptional Items	0	0	0
PBDT	680	363	795
Depreciation	223	108	122
PBT	457	255	674
Tax	154	83	205
Profit After Tax	304	171	469	77	-35
PAT margins	13.97%	9.42%	18.18%
Equity Capital	307.99	307.63	307.63
Face Value(InRs)	2.00	2.00	2.00
EPS	1.97	1.12	3.05	76	-35
Figures in INR Crore.EPS represents Ajd EPS

Regards,

Team Microsec Research

Dii, FII trading activity on NSE and BSE 19-10-2012

Category		Buy	Sell	Net
		Value	Value	Value
FII		2255.89	2175.78	80.11
DII		1025.99	913.93	112.06

 

-- 

Trading Today (October 19, 2012) ::Emkay

Trading Today (October 19, 2012)

From Our Technical Desk From The Dealing Desk Market Outlook: Markets ended in green on account of strong global cues. All the major sectoral indices ended in green, Realty and Banking counters being the highest gainers.  Nifty:       Nifty smartly recovered from the days low and ended in green. The 5 DMA at 5,689 will act as an immediate support for Nifty. Resistance is seen at 5,750 and major positive development can be seen only if Nifty closes above 5,750 levels. A close above this level will further extend the rally up to 5,820/5,850 levels. Support: Major support level 5,700/5,680. Investment Ideas Dhanuka Agritech CMP @ Rs. 130 (Target Price: Rs.150) Trading Ideas Positive bias - Strides Acrolab (Target 960), Shashun Pharma (Target 186) & Aurobindo Pharma (Target 180). Traders maintain stop loss accordingly. Statistical Data Derivatives Update Advance Decline Ratio Sector updates Exchange Volumes Implied Volatility for ATM Options Put Call Ratio for (Open Interest) FII - MF Activity World Markets Currency Click here to read report: Trading Today

Derivatives Info Kit [For October 19, 2012] Sharekhan

Derivatives Info Kit [For October 19, 2012] Sharekhan www.sharekhan.com

Summary of Contents     DERIVATIVES INFO KIT   Click here to read report: Derivatives Info Kit

19 Oct: News (click on link to read article) IFCI research

Morning News (click on link to read article)

Economic Times		Business Standard
Ø  Fortis Healthcare raises $510 mn through stake sale Ø  ACC, Ambuja Cements say rising costs could offset better demand Ø  Tata, SAIL differ on need for steel-making equipment facility Ø  Hindustan Zinc Limited reports 15% rise in Q2 net on higher lead and silver output Ø  ITC standalone Q2 PAT seen at Rs 1,745 crore Ø  India emerges as IInd largest global tobacco producer		Ø  BSNL, MTNL won't participate in spectrum auction Ø  DIIs net sellers of Rs 185 cr in cash mkt today Ø  Gold futures rise marginally on festive demand Ø  Cipla gets tentative US nod for HIV tablets Ø  Bridgestone to spend $3.5 bn to expand tyre capacity in 2013 Ø  Indian securitisation market adapting well to revised norms: CRISIL
Business Line		Mint
Ø  Disclosures made in IPO draft papers legally binding: SEBI Ø  Banks may need more capital than RBI’s estimates: Rangarajan Ø  Govt to set up panel on internal trade reforms by month-end Ø  Govt may hike import duty on white sugar to 20% next month Ø  CanFin Homes Q2 profits up 31.25%		Ø  Panel decides on retrospective charge on excess spectrum Ø  Indian Hotels makes $1.86 bn bid for Orient Express along with Italian fund Ø  Business finally begins from home for TCS Ø  Court’s approval needed to tap phones: Panel Ø  Mindtree: investors waiting for large deals
Financial Express		DNA
Ø  TCI demands R1,500 cr from CIL board for under-pricing coal Ø  'India current account deficit at record' Ø  Cut rates or risk India calamity: Bankers Ø  Telecom shares hit by 900 mega hertz woe Ø  Ramky acquires Entech Industries' arm Ø  Investment board will fast-track decisions, pump up coal & power		Ø  ED attaches Rs 822 crore worth assets of Satyam's Raju, others Ø  Sops gone, F&O volumes on BSE tanked in September Ø  Steady deals, Rupee help HCL Tech beat Street Ø  Sanofi sees a sweet spot in local insulin market

--